146 related articles for article (PubMed ID: 3285350)
1. Vitiligo and antibodies to melanocytes.
Bystryn JC; Pfeffer S
Prog Clin Biol Res; 1988; 256():195-206. PubMed ID: 3285350
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms in vitiligo.
Bystryn JC
Immunol Ser; 1989; 46():447-73. PubMed ID: 2488866
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of melanocytes in vitiligo results from antibody penetration.
Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
[TBL] [Abstract][Full Text] [Related]
5. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
Cui J; Bystryn JC
Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
[TBL] [Abstract][Full Text] [Related]
6. Current remedies for vitiligo.
Abu Tahir M; Pramod K; Ansari SH; Ali J
Autoimmun Rev; 2010 May; 9(7):516-20. PubMed ID: 20149899
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
[TBL] [Abstract][Full Text] [Related]
8. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
9. [Melanocyte antibodies in idiopathic vitiligo (author's transl)].
Höfs T; Zugehör M; Morenz J
Dermatol Monatsschr; 1981 Nov; 167(11):685-92. PubMed ID: 7044847
[No Abstract] [Full Text] [Related]
10. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
Li YL; Yu CL; Yu HS
J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
[TBL] [Abstract][Full Text] [Related]
11. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
12. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
Chen JP; Li HP; Jin SH; Zhang JT; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
[TBL] [Abstract][Full Text] [Related]
13. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation.
Naughton GK; Eisinger M; Bystryn JC
J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421
[TBL] [Abstract][Full Text] [Related]
15. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?
Ram M; Shoenfeld Y
Ann N Y Acad Sci; 2007 Sep; 1110():410-25. PubMed ID: 17911456
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies in vitiligo. Clinical significance].
Morgan M; Castells A; Ramírez A
Med Cutan Ibero Lat Am; 1986; 14(2):139-42. PubMed ID: 3528710
[TBL] [Abstract][Full Text] [Related]
17. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo.
Palermo B; Garbelli S; Mantovani S; Scoccia E; Da Prada GA; Bernabei P; Avanzini MA; Brazzelli V; Borroni G; Giachino C
Eur J Immunol; 2005 Nov; 35(11):3153-62. PubMed ID: 16224813
[TBL] [Abstract][Full Text] [Related]
18. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
Peserico A; Rigon F; Semenzato G; Caretto A; Pasini CV; Betterle C
Arch Dermatol; 1981 Nov; 117(11):751-2. PubMed ID: 7316541
[No Abstract] [Full Text] [Related]
19. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
Kroon MW; Kemp EH; Wind BS; Krebbers G; Bos JD; Gawkrodger DJ; Wolkerstorfer A; van der Veen JP; Luiten RM
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1172-5. PubMed ID: 22404127
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
